EHR

STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy

Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...

STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy

Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...

STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy

Recordati Joins Boehringer Ingelheim Venture Fund in Financing Round, with Participation from Delos and Blue Bay CapitalNew Investment, Combined with...

Care Management Solutions Market Surges to USD 14.5 Billion by 2033, Propelled by 9.8% CAGR – Verified Market Reports®

The Care Management Solutions Market is poised for robust expansion driven by escalating demand for integrated patient care coordination, regulatory...

Black Book Recaps 2025 Research Announcements and Client‑Rated Honors; Reaffirms Vendor‑Agnostic, Independently Validated Intelligence and 2026 Commitments

In 2025, Black Book expanded global healthcare IT research coverage; issued 32 complimentary, vendor-neutral benchmarking reports; advanced a 36‑KPI qualitative...

Middle East Health IT Modernization Is Accelerating But Procurement Is Tightening Around Bilingual Operations, Sovereign Hosting, and Verifiable AI

Black Book Survey of health IT leaders across five high-activity Middle East markets finds sovereignty-compatible architectures and Arabic/English workflow readiness...

error: Content is protected !!